Singapore, March 21, 2024 —FedEx Express (FedEx), a subsidiary of FedEx Corp. (NYSE: FDX) and one of the world’s largest express transportation companies, has been named ‘Overall Logistics & Supply Chain Management Supplier of the Year’ and also received the ‘Best Logistics & Supply Chain Management Supplier Award: Last Mile Implementation’ at the Asia-Pacific Biopharma Excellence Awards 2024 (ABEA 2024).
Organized by IMAPAC, ABEA 2024 seeks to give recognition to exceptional bioprocessing, logistics and supply chain management, as well as clinical trials experts, organizations, and technologies in the Asia region.
FedEx has built its healthcare capabilities over decades, including its dedicated healthcare team and cold chain network, to ship vaccines, biologics, and medical aid all around the world. With a global network of more than 680 aircraft and 200,000 vehicles, and four Life Science Centers in the region including South Korea, Japan, Singapore and India, FedEx enables movement of healthcare shipments using temperature-controlled solutions and real-time monitoring using FedEx SenseAware to help protect shipment integrity. The company’s dedicated service, FedEx Clinical Care, provides an end-to-end shipping solution designed to transport precious biological samples at the exact speed and temperature required for safe, compliant clinical trials.
“The healthcare industry has very specific and carefully regulated logistics needs. Being recognized by voters among the biopharma community is the highest possible recognition we can receive,” said Salil Chari, senior vice president, Marketing and Customer Experience, Asia Pacific, Middle East, and Africa Region, FedEx Express. “Our mission is to make supply chains smarter for everyone. We are transforming to build the world’s most flexible, efficient, and intelligent logistics network by using advanced sensor-based monitoring and predictive tools to ensure critical shipments reach their destinations safely. Our healthcare customers can be confident our innovative solutions will meet all their shipping needs.”
The ABEA 2024 was held in conjunction with 11th Biologics Manufacturing Asia, 8th BioLogistics World Asia and 2nd Clinical Trials Festival Asia on 20th March 2024 in Singapore, gathering hundreds of biopharma industry leaders. To learn more about the ABEA 2024 awards, please visit.
